Vaxcyte Inc

PCVXNASDAQ · USD
60.37USD0.00 (+2.73%)
2210

Vaxcyte Inc (PCVX) Wheel Strategy

PCVX wheel strategy scan found 23 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 92.9%.

Read more

Running a PCVX wheel strategy lets you generate consistent premium income on Vaxcyte Inc while setting your own entry and exit prices on the underlying. Vaxcyte Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own PCVX, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best PCVX wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on PCVX, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable PCVX wheel from a losing one.

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis.

The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the PCVX wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your PCVX wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Oct 16, 202655.00$3.50$4.20-0.353090%54.7%92.9%710
Sep 18, 202655.00$0.15$0.23-0.13290%83.7%74.7%312
Nov 20, 202650.00$4.00$6.40-0.286590%58.6%71.9%0
Oct 16, 202650.00$1.90$2.90-0.243090%68.0%70.6%4,695
Nov 20, 202645.00$2.50$4.75-0.216590%68.4%59.3%0
Dec 18, 202650.00$4.50$6.90-0.289390%54.6%54.2%772
Jan 15, 202750.00$5.00$7.40-0.2812190%51.7%44.6%177
Nov 20, 202640.00$0.65$3.08-0.156590%77.9%43.2%0
Dec 18, 202645.00$3.90$4.85-0.219390%63.0%42.3%34,383
Nov 20, 202635.00$0.15$2.53-0.126590%86.5%40.5%4

As of September 17, 2026

Run the Wheel on PCVX With Confidence

Find the best PCVX wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial